Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swantje Völler

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Pharmacology|December 6, 2017
Pharmacokinetics of recombinant asparaginase in children with acute lymphoblastic leukemiaSwantje Völler, Uwe Pichlmeier, Anke Zens, et al.
Minerva Pediatrics|October 27, 2020
Severity parameters for asphyxia or hypoxic-ischemic encephalopathy do not explain inter-individual variability in the pharmacokinetics of phenobarbital in newborns treated with therapeutic hypothermiaPavla Pokorná, Danica Michaličková, Swantje Völler, et al.
Journal of Clinical Pharmacology|May 2, 2025
A Systematic Evaluation of the Dosing Regimens for Approved Targeted Therapies and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma From a Project OPTIMUS PerspectiveZhiyuan Tan, Swantje Völler, Aymara Sancho-Araiz, et al.
Clinical Pharmacokinetics|May 1, 2015
Age-Dependent Pharmacokinetics of Doxorubicin in Children with CancerSwantje Völler, Joachim Boos, Miriam Krischke, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 26, 2020
Genetic Polymorphisms Affecting Cardiac Biomarker Concentrations in Children with Cancer: an Analysis from the "European Paediatric Oncology Off-patents Medicines Consortium" (EPOC) TrialFarina Hellmann, Swantje Völler, Miriam Krischke, et al.
Clinical Pharmacokinetics|September 20, 2016
Towards a Model-Based Dose Recommendation for Doxorubicin in ChildrenSwantje Völler, Georg Hempel, Gudrun Würthwein, et al.
Clinical Pharmacokinetics|November 13, 2021
Pre- and Postnatal Maturation are Important for Fentanyl Exposure in Preterm and Term Newborns: A Pooled Population Pharmacokinetic StudyYunjiao Wu, Swantje Völler, Robert B Flint, et al.
The AAPS Journal|February 25, 2022
Prediction of glomerular filtration rate maturation across preterm and term neonates and young infants using inulin as markerYunjiao Wu, Karel Allegaert, Robert B Flint, et al.
The Journal of Antimicrobial Chemotherapy|June 16, 2025
Evaluation of amoxicillin and benzylpenicillin therapy in early-onset neonatal sepsis: a pharmacometric external validation and simulation studyTom C Zwart, Dimitra Eleftheriou, Sophie J Jansen, et al.
Neonatology|August 26, 2020
Use of Continuous Physiological Monitor Data to Evaluate Doxapram Therapy in Preterm InfantsJarinda A Poppe, Willem van Weteringen, Swantje Völler, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|December 6, 2017
Pharmacokinetics of recombinant asparaginase in children with acute lymphoblastic leukemiaSwantje Völler, Uwe Pichlmeier, Anke Zens, et al.
Minerva Pediatrics|October 27, 2020
Severity parameters for asphyxia or hypoxic-ischemic encephalopathy do not explain inter-individual variability in the pharmacokinetics of phenobarbital in newborns treated with therapeutic hypothermiaPavla Pokorná, Danica Michaličková, Swantje Völler, et al.
Journal of Clinical Pharmacology|May 2, 2025
A Systematic Evaluation of the Dosing Regimens for Approved Targeted Therapies and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma From a Project OPTIMUS PerspectiveZhiyuan Tan, Swantje Völler, Aymara Sancho-Araiz, et al.
Clinical Pharmacokinetics|May 1, 2015
Age-Dependent Pharmacokinetics of Doxorubicin in Children with CancerSwantje Völler, Joachim Boos, Miriam Krischke, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 26, 2020
Genetic Polymorphisms Affecting Cardiac Biomarker Concentrations in Children with Cancer: an Analysis from the "European Paediatric Oncology Off-patents Medicines Consortium" (EPOC) TrialFarina Hellmann, Swantje Völler, Miriam Krischke, et al.
Clinical Pharmacokinetics|September 20, 2016
Towards a Model-Based Dose Recommendation for Doxorubicin in ChildrenSwantje Völler, Georg Hempel, Gudrun Würthwein, et al.
Clinical Pharmacokinetics|November 13, 2021
Pre- and Postnatal Maturation are Important for Fentanyl Exposure in Preterm and Term Newborns: A Pooled Population Pharmacokinetic StudyYunjiao Wu, Swantje Völler, Robert B Flint, et al.
The AAPS Journal|February 25, 2022
Prediction of glomerular filtration rate maturation across preterm and term neonates and young infants using inulin as markerYunjiao Wu, Karel Allegaert, Robert B Flint, et al.
The Journal of Antimicrobial Chemotherapy|June 16, 2025
Evaluation of amoxicillin and benzylpenicillin therapy in early-onset neonatal sepsis: a pharmacometric external validation and simulation studyTom C Zwart, Dimitra Eleftheriou, Sophie J Jansen, et al.
Neonatology|August 26, 2020
Use of Continuous Physiological Monitor Data to Evaluate Doxapram Therapy in Preterm InfantsJarinda A Poppe, Willem van Weteringen, Swantje Völler, et al.
Pageof 3